Positional isomerism markedly affects the growth inhibition of colon cancer cells by nitric oxide-donating aspirin in vitro and in vivo
about
Therapeutic effects of nitric oxide-aspirin hybrid drugsNitric oxide and cisplatin resistance: NO easy answers.NOSH-Aspirin: A Novel Nitric Oxide-Hydrogen Sulfide-Releasing Hybrid: A New Class of Anti-inflammatory Pharmaceuticals.Inhibition of pancreatic intraepithelial neoplasia progression to carcinoma by nitric oxide-releasing aspirin in p48(Cre/+)-LSL-Kras(G12D/+) miceNSAIDs and Colorectal Cancer Control: Promise and ChallengesNCX-4040, a nitric oxide-releasing aspirin, sensitizes drug-resistant human ovarian xenograft tumors to cisplatin by depletion of cellular thiols.The Antineoplastic Effect of Nitric Oxide-Donating Acetylsalicylic Acid (NO-ASA) in Chronic Lymphocytic Leukemia (CLL) Cells is Highly Dependent on its Positional Isomerism.NO-donating aspirin inhibits angiogenesis by suppressing VEGF expression in HT-29 human colon cancer mouse xenograftsNitric Oxide-Releasing Hybrid Drugs Target Cellular Processes Through S-Nitrosylation.Chemopreventive agents induce oxidative stress in cancer cells leading to COX-2 overexpression and COX-2-independent cell death.Phosphoaspirin (MDC-43), a novel benzyl ester of aspirin, inhibits the growth of human cancer cell lines more potently than aspirin: a redox-dependent effect.NO-donating NSAIDs and cancer: an overview with a note on whether NO is required for their action.NO-Donating NSAIDs, PPARdelta, and Cancer: Does PPARdelta Contribute to Colon Carcinogenesis?NO-donating aspirin inhibits the activation of NF-kappaB in human cancer cell lines and Min mice.Dithiolethione modified valproate and diclofenac increase E-cadherin expression and decrease proliferation of non-small cell lung cancer cells.Modulation of carcinogen metabolism by nitric oxide-aspirin 2 is associated with suppression of DNA damage and DNA adduct formation.Aspirin and low-dose nitric oxide-donating aspirin increase life span in a Lynch syndrome mouse model.Biology and therapeutic potential of hydrogen sulfide and hydrogen sulfide-releasing chimerasNitric Oxide-Releasing Aspirin Suppresses NF-κB Signaling in Estrogen Receptor Negative Breast Cancer Cells in Vitro and in Vivo.Flurbiprofen benzyl nitrate (NBS-242) inhibits the growth of A-431 human epidermoid carcinoma cells and targets β-catenin.Nitric oxide-donating aspirin induces G2/M phase cell cycle arrest in human cancer cells by regulating phase transition proteinsStructure-activity relationship study of novel anticancer aspirin-based compounds.Hydrogen sulfide induces human colon cancer cell proliferation: role of Akt, ERK and p21.Nitrates and NO-NSAIDs in cancer chemoprevention and therapy: in vitro evidence querying the NO donor functionalityThe differential cell signaling effects of two positional isomers of the anticancer NO-donating aspirin.Biological application of water-based electrochemically synthesized CuO leaf-like arrays: SERS response modulated by the positional isomerism and interface type.The dichotomous role of H2S in cancer cell biology? Déjà vu all over again.A Fluorescence Spot Test for Salicylate Determination
P2860
Q28210282-6ABC2A2D-07E4-48EC-8FC6-A121C5A29AF4Q34574620-320B9968-BC38-4662-8BA2-CEE88EC86AD3Q36176425-CE3C2987-23F4-470B-9EED-2E31EC70BC81Q36282723-4E2B52A5-7777-4B14-A59F-CEFEA51B7791Q36381490-54119697-51FC-4E5D-9503-DB0681F2AE98Q36495493-8922150B-3543-4150-A70F-5E755657115BQ36612625-12EC90F0-6C0F-43B8-AB9A-BAD9B074647FQ36857555-804A6223-5879-467A-8459-5F81DD7CCFC6Q36882663-6DDB0C70-CEB7-4007-8E10-3BB992EE587FQ37090409-6279AE7C-1F9C-4B8A-AE0D-4D6EDD556C77Q37116334-03D5B327-7A8B-42E1-A4FA-C0D6128DC100Q37166556-00C9355B-C320-4991-8843-3C9B89FCC60DQ37182798-D5D47F26-061D-46C6-8470-B543A2CD7C32Q37185879-E9E5B966-BB26-46C9-A3A0-774EB5717BA4Q37328516-3EA0BE4E-177A-4293-A406-EE0769AF9699Q37372211-61C52E8C-FF59-4922-BAC8-F5340ED2C7EDQ37709953-37DAFCC3-AC6C-4179-B3C2-356CB3D9D238Q38056004-CB8E9FA2-9158-4648-8BC7-B1318776E4FBQ38852006-D2591825-DCD8-4DB3-AC8B-92D9CF607912Q39149369-35DF0185-A929-42B1-86EF-B0B46E6D1D61Q39354764-AE69FF03-EE47-4C86-9C2E-7D4CDFF7CF6BQ39497398-1AD72B33-5E49-45FD-95B3-803C0C2BB695Q39735129-2ECDD35E-ADD1-4DD8-9154-8604DFA4C66EQ39981234-E2142648-08E3-4B27-B187-F547973DCC2FQ41858880-1D54C797-A867-4B1A-83C6-89F8CA7C0B1CQ47317823-3334F4CA-AB02-4C51-BE60-940593FF9EB4Q49346285-7426B9AA-E6BB-4279-BDB8-3F34C4C7CF39Q58130221-C28B1573-0B5D-417A-966F-9C6AA68195A0
P2860
Positional isomerism markedly affects the growth inhibition of colon cancer cells by nitric oxide-donating aspirin in vitro and in vivo
description
2005 nî lūn-bûn
@nan
2005 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մարտին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Positional isomerism markedly ...... g aspirin in vitro and in vivo
@ast
Positional isomerism markedly ...... g aspirin in vitro and in vivo
@en
Positional isomerism markedly ...... g aspirin in vitro and in vivo
@nl
type
label
Positional isomerism markedly ...... g aspirin in vitro and in vivo
@ast
Positional isomerism markedly ...... g aspirin in vitro and in vivo
@en
Positional isomerism markedly ...... g aspirin in vitro and in vivo
@nl
prefLabel
Positional isomerism markedly ...... g aspirin in vitro and in vivo
@ast
Positional isomerism markedly ...... g aspirin in vitro and in vivo
@en
Positional isomerism markedly ...... g aspirin in vitro and in vivo
@nl
P2093
P356
P1476
Positional isomerism markedly ...... g aspirin in vitro and in vivo
@en
P2093
Athanasios Glekas
Basil Rigas
Francesca Benedini
Jennie L Williams
Jianjun Gao
Khosrow Kashfi
Simona Borgo
P304
P356
10.1124/JPET.104.075994
P407
P577
2005-03-01T00:00:00Z